Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Total Assets of $26.73 million for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -4.1% in Total Assets from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $6.83 million | Q3 2011: $1.89 million | Q1 2012: $226.0 thousand | Q3 2012: $428.0 thousand | Q1 2013: $521.0 thousand | Q2 2013: $2.44 million | Q3 2013: $7.64 million | Q1 2014: $12.51 million | Q2 2014: $12.58 million | Q3 2014: $29.39 million | Q1 2015: $49.41 million | Q2 2015: $64.25 million | Q3 2015: $51.64 million | Q1 2016: $62.23 million | Q2 2016: $51.61 million | Q3 2016: $48.94 million | Q1 2017: $48.31 million | Q2 2017: $47.38 million | Q3 2017: $49.75 million | Q1 2018: $49.78 million | Q2 2018: $48.48 million | Q3 2018: $46.33 million | Q1 2019: $24.47 million | Q2 2019: $14.70 million | Q3 2019: $10.15 million | Q1 2020: $9.18 million | Q2 2020: $14.91 million | Q3 2020: $27.21 million | Q1 2021: $32.46 million | Q2 2021: $28.77 million | Q3 2021: $28.22 million | Q1 2022: $30.66 million | Q2 2022: $27.52 million | Q3 2022: $31.10 million | Q1 2023: $32.87 million | Q2 2023: $28.44 million | Q3 2023: $31.49 million | Q1 2024: $28.57 million | Q2 2024: $28.23 million | Q3 2024: $29.32 million | Q4 2024: $26.73 million | Q1 2025: $27.51 million | Q2 2025: $29.55 million | Q3 2025: $30.61 million.
- Over the full 15 years of available data (2010 to 2024), NORTHWEST BIOTHERAPEUTICS INC's Total Assets has grown by 8,991.2%.
- Historical annual values: Fiscal year 2024: $26.73 million | Fiscal year 2023: $27.87 million | Fiscal year 2022: $31.32 million | Fiscal year 2021: $40.16 million | Fiscal year 2020: $32.90 million | Fiscal year 2019: $10.64 million | Fiscal year 2018: $24.67 million | Fiscal year 2017: $48.91 million | Fiscal year 2016: $52.91 million | Fiscal year 2015: $70.80 million | Fiscal year 2014: $56.46 million | Fiscal year 2013: $18.78 million | Fiscal year 2012: $7.57 million | Fiscal year 2011: $212.0 thousand | Fiscal year 2010: $294.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: